Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology

Ali Ezzati, Cuiling Wang, Richard B. Lipton, Dorothea Altschul, Mindy J. Katz, Dennis W Dickson, Carol A. Derby

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: To examine the association between vascular pathology and rate of cognitive decline in older adults independent of Alzheimer's disease (AD) pathology. Design: Prospective cohort study. Setting: Community sample. Participants: Individuals from the Einstein Aging Study autopsy series (N = 62). Measurements: The Blessed Information-Memory-Concentration (BIMC) test was used to assess global cognitive status. AD pathology was quantified according to Braak stage (<3 vs ≥ 3). Vascular pathology was quantified using a previously reported macrovascular lesion (MVL) score. The association between vascular pathology and antemortem rates of cognitive decline adjusted for level of AD pathology was assessed using linear mixed-effects models. Results: Mean age was 81.8 at enrollment and 89.0 at death. Participants with more than two MVLs had faster cognitive decline than those with no MVLs (difference in annual rate of change in BIMC 0.74 points/yr, P = .03). Braak stage was also associated with cognitive decline (difference 0.57 points/yr, P = .03). The difference in rate of cognitive decline between those with more than two MVLs and those free of vascular lesions persisted after adjustment for AD pathology (difference in rate of change in BIMC 0.68 points/yr, P = .04). The effect of vascular pathology on cognitive decline was not significantly different according to AD pathology. Conclusion: Vascular brain pathology is associated with rate of cognitive decline after adjusting for level of AD pathology.

Original languageEnglish (US)
JournalJournal of the American Geriatrics Society
DOIs
StateAccepted/In press - 2017

Fingerprint

Blood Vessels
Alzheimer Disease
Pathology
Cognitive Dysfunction
Autopsy
Cohort Studies
Prospective Studies
Brain

Keywords

  • Alzheimer disease pathology
  • Cerebrovascular disease
  • Cognitive decline
  • Vascular pathology

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology. / Ezzati, Ali; Wang, Cuiling; Lipton, Richard B.; Altschul, Dorothea; Katz, Mindy J.; Dickson, Dennis W; Derby, Carol A.

In: Journal of the American Geriatrics Society, 2017.

Research output: Contribution to journalArticle

Ezzati, Ali ; Wang, Cuiling ; Lipton, Richard B. ; Altschul, Dorothea ; Katz, Mindy J. ; Dickson, Dennis W ; Derby, Carol A. / Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology. In: Journal of the American Geriatrics Society. 2017.
@article{dc265d71c97e4493bb555a064a75edcf,
title = "Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology",
abstract = "Objectives: To examine the association between vascular pathology and rate of cognitive decline in older adults independent of Alzheimer's disease (AD) pathology. Design: Prospective cohort study. Setting: Community sample. Participants: Individuals from the Einstein Aging Study autopsy series (N = 62). Measurements: The Blessed Information-Memory-Concentration (BIMC) test was used to assess global cognitive status. AD pathology was quantified according to Braak stage (<3 vs ≥ 3). Vascular pathology was quantified using a previously reported macrovascular lesion (MVL) score. The association between vascular pathology and antemortem rates of cognitive decline adjusted for level of AD pathology was assessed using linear mixed-effects models. Results: Mean age was 81.8 at enrollment and 89.0 at death. Participants with more than two MVLs had faster cognitive decline than those with no MVLs (difference in annual rate of change in BIMC 0.74 points/yr, P = .03). Braak stage was also associated with cognitive decline (difference 0.57 points/yr, P = .03). The difference in rate of cognitive decline between those with more than two MVLs and those free of vascular lesions persisted after adjustment for AD pathology (difference in rate of change in BIMC 0.68 points/yr, P = .04). The effect of vascular pathology on cognitive decline was not significantly different according to AD pathology. Conclusion: Vascular brain pathology is associated with rate of cognitive decline after adjusting for level of AD pathology.",
keywords = "Alzheimer disease pathology, Cerebrovascular disease, Cognitive decline, Vascular pathology",
author = "Ali Ezzati and Cuiling Wang and Lipton, {Richard B.} and Dorothea Altschul and Katz, {Mindy J.} and Dickson, {Dennis W} and Derby, {Carol A.}",
year = "2017",
doi = "10.1111/jgs.14903",
language = "English (US)",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology

AU - Ezzati, Ali

AU - Wang, Cuiling

AU - Lipton, Richard B.

AU - Altschul, Dorothea

AU - Katz, Mindy J.

AU - Dickson, Dennis W

AU - Derby, Carol A.

PY - 2017

Y1 - 2017

N2 - Objectives: To examine the association between vascular pathology and rate of cognitive decline in older adults independent of Alzheimer's disease (AD) pathology. Design: Prospective cohort study. Setting: Community sample. Participants: Individuals from the Einstein Aging Study autopsy series (N = 62). Measurements: The Blessed Information-Memory-Concentration (BIMC) test was used to assess global cognitive status. AD pathology was quantified according to Braak stage (<3 vs ≥ 3). Vascular pathology was quantified using a previously reported macrovascular lesion (MVL) score. The association between vascular pathology and antemortem rates of cognitive decline adjusted for level of AD pathology was assessed using linear mixed-effects models. Results: Mean age was 81.8 at enrollment and 89.0 at death. Participants with more than two MVLs had faster cognitive decline than those with no MVLs (difference in annual rate of change in BIMC 0.74 points/yr, P = .03). Braak stage was also associated with cognitive decline (difference 0.57 points/yr, P = .03). The difference in rate of cognitive decline between those with more than two MVLs and those free of vascular lesions persisted after adjustment for AD pathology (difference in rate of change in BIMC 0.68 points/yr, P = .04). The effect of vascular pathology on cognitive decline was not significantly different according to AD pathology. Conclusion: Vascular brain pathology is associated with rate of cognitive decline after adjusting for level of AD pathology.

AB - Objectives: To examine the association between vascular pathology and rate of cognitive decline in older adults independent of Alzheimer's disease (AD) pathology. Design: Prospective cohort study. Setting: Community sample. Participants: Individuals from the Einstein Aging Study autopsy series (N = 62). Measurements: The Blessed Information-Memory-Concentration (BIMC) test was used to assess global cognitive status. AD pathology was quantified according to Braak stage (<3 vs ≥ 3). Vascular pathology was quantified using a previously reported macrovascular lesion (MVL) score. The association between vascular pathology and antemortem rates of cognitive decline adjusted for level of AD pathology was assessed using linear mixed-effects models. Results: Mean age was 81.8 at enrollment and 89.0 at death. Participants with more than two MVLs had faster cognitive decline than those with no MVLs (difference in annual rate of change in BIMC 0.74 points/yr, P = .03). Braak stage was also associated with cognitive decline (difference 0.57 points/yr, P = .03). The difference in rate of cognitive decline between those with more than two MVLs and those free of vascular lesions persisted after adjustment for AD pathology (difference in rate of change in BIMC 0.68 points/yr, P = .04). The effect of vascular pathology on cognitive decline was not significantly different according to AD pathology. Conclusion: Vascular brain pathology is associated with rate of cognitive decline after adjusting for level of AD pathology.

KW - Alzheimer disease pathology

KW - Cerebrovascular disease

KW - Cognitive decline

KW - Vascular pathology

UR - http://www.scopus.com/inward/record.url?scp=85017531261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017531261&partnerID=8YFLogxK

U2 - 10.1111/jgs.14903

DO - 10.1111/jgs.14903

M3 - Article

C2 - 28407205

AN - SCOPUS:85017531261

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

ER -